Cumberland PharmaceuticalsCPIX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 32 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, up 3 from Q1 2026. 8 opened new positions and 5 sold out. The largest holders were Ikarian Capital, LLC ($3.3M), Renaissance Technologies ($3.1M) and Vanguard Capital Management LLC ($2.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $350K |
| Exits | 5 | $525K |
All 13F filers, Q1 2026 → Q2 2026: 230,501 shares bought and 523,116 shares sold, net −292,615 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Ikarian Capital, LLC | 0.53% | Reduce -9.0% | 503,153 | $3.3M |
| Renaissance Technologies | 0.00% | Add +1.6% | 478,263 | $3.1M |
| Vanguard Capital Management LLC | 0.00% | Add +4.9% | 379,478 | $2.5M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -15.6% | 233,305 | $1.5M |
| Boothbay Fund Management, LLC | 0.01% | Reduce -11.9% | 112,544 | $729K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.1% | 108,413 | $703K |
| Perceptive Advisors LLC | 0.01% | Reduce -50.8% | 96,982 | $628K |
| Citadel Advisors | 0.00% | Add +341.0% | 73,391 | $476K |
| BlackRock, Inc. | 0.00% | Add +11.7% | 63,547 | $412K |
| Bank of New York Mellon Corp | 0.00% | No change | 58,458 | $379K |
| Jane Street Group, LLC | 0.00% | Add +288.4% | 56,741 | $368K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +20.4% | 54,909 | $356K |
| State Street Corp. | 0.00% | No change | 39,510 | $256K |
| UBS Group AG | 0.00% | Add +407.6% | 26,339 | $171K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -84.0% | 26,200 | $170K |
| Bailard, Inc. | 0.00% | New | 24,624 | $160K |
| Quadrature Capital Ltd | 0.00% | New | 24,014 | $156K |
| Two Sigma Investments, LP | 0.00% | Add +116.3% | 23,981 | $155K |
| Northern Trust Corp. | 0.00% | Add +12.0% | 21,953 | $142K |
| Arrowstreet Capital, Limited Partnership | 0.00% | No change | 20,252 | $131K |
| Cresset Asset Management, LLC | 0.00% | No change | 19,475 | $126K |
| XTX Topco Ltd | 0.00% | Reduce -41.2% | 14,118 | $91K |
| Simplex Trading, LLC | 0.00% | New | 4,544 | $29K |
| Morgan Stanley | 0.00% | Add +0.0% | 3,261 | $21K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 437 | $3K |
| Institute for Wealth Management, LLC. | 0.00% | New | 352 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 200 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 191 | $1K |
| Wells Fargo & Company | 0.00% | No change | 100 | $648 |
| Barclays PLC | 0.00% | New | 48 | $311 |
| FMR LLC | 0.00% | New | 21 | $136 |
| Huntington National Bank | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.